Shigeo Fuji

3.4k total citations
151 papers, 1.9k citations indexed

About

Shigeo Fuji is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Shigeo Fuji has authored 151 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Hematology, 73 papers in Immunology and 42 papers in Oncology. Recurrent topics in Shigeo Fuji's work include Hematopoietic Stem Cell Transplantation (76 papers), T-cell and Retrovirus Studies (34 papers) and T-cell and B-cell Immunology (24 papers). Shigeo Fuji is often cited by papers focused on Hematopoietic Stem Cell Transplantation (76 papers), T-cell and Retrovirus Studies (34 papers) and T-cell and B-cell Immunology (24 papers). Shigeo Fuji collaborates with scholars based in Japan, United States and Germany. Shigeo Fuji's co-authors include Takahiro Fukuda, Markus Kapp, Hermann Einsele, Saiko Kurosawa, Ryuji Tanosaki, Akihiro Ohmoto, Bipin N. Savani, Yoshitaka Inoue, Sung Won Kim and Yoshihiro Inamoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Shigeo Fuji

144 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeo Fuji Japan 24 920 672 536 244 213 151 1.9k
Saiko Kurosawa Japan 22 920 1.0× 344 0.5× 341 0.6× 164 0.7× 340 1.6× 99 1.5k
Shigesaburo Miyakoshi Japan 26 982 1.1× 370 0.6× 596 1.1× 78 0.3× 210 1.0× 90 1.7k
José Orlando Bordin Brazil 27 1.2k 1.3× 378 0.6× 230 0.4× 118 0.5× 195 0.9× 120 2.4k
Susan Light United States 17 410 0.4× 749 1.1× 326 0.6× 97 0.4× 193 0.9× 22 1.9k
Kavita Raj United Kingdom 19 903 1.0× 330 0.5× 255 0.5× 61 0.3× 143 0.7× 62 1.2k
Marie Garvey Canada 21 638 0.7× 223 0.3× 159 0.3× 77 0.3× 99 0.5× 66 1.3k
Sergio Giralt United States 21 3.0k 3.3× 719 1.1× 799 1.5× 230 0.9× 1.0k 4.9× 40 3.6k
Flore Sicre de Fontbrune France 22 837 0.9× 861 1.3× 192 0.4× 66 0.3× 137 0.6× 107 1.9k
T. K. Chan China 23 431 0.5× 218 0.3× 499 0.9× 91 0.4× 98 0.5× 71 1.8k
Hélène Schoemans Belgium 18 640 0.7× 224 0.3× 338 0.6× 144 0.6× 189 0.9× 69 1.3k

Countries citing papers authored by Shigeo Fuji

Since Specialization
Citations

This map shows the geographic impact of Shigeo Fuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeo Fuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeo Fuji more than expected).

Fields of papers citing papers by Shigeo Fuji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeo Fuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeo Fuji. The network helps show where Shigeo Fuji may publish in the future.

Co-authorship network of co-authors of Shigeo Fuji

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeo Fuji. A scholar is included among the top collaborators of Shigeo Fuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeo Fuji. Shigeo Fuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuji, Shigeo. (2024). Chemotherapy and allo-HSCT for young patients with aggressive ATL. Leukemia Research. 147. 107596–107596. 2 indexed citations
2.
Fuji, Shigeo, Ayumu Ito, Noriko Doki, et al.. (2024). Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation. Transplantation and Cellular Therapy. 30(5). 514.e1–514.e13.
3.
4.
Fuji, Shigeo, Junichi Sugita, Yuho Najima, et al.. (2023). Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation. British Journal of Haematology. 204(3). 959–966. 6 indexed citations
5.
Fuji, Shigeo, et al.. (2023). Apoptotic abnormal lymphocytes as a possible early indicator of clinical response in patients with ATL. SHILAP Revista de lepidopterología. 5(1). 274–275. 1 indexed citations
6.
7.
Ohmoto, Akihiro, et al.. (2022). Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia. Bone Marrow Transplantation. 57(6). 874–880. 10 indexed citations
8.
Fuji, Shigeo, et al.. (2022). Nutritional support in allogeneic hematopoietic stem cell transplantation Asian perspective. PubMed. 5(2). 54–60. 5 indexed citations
9.
10.
Shiratori, Souichi, Junichi Sugita, Shigeo Fuji, et al.. (2021). Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors. Bone Marrow Transplantation. 56(9). 2231–2240. 5 indexed citations
11.
Inoue, Yoshitaka, Keiji Okinaka, Shigeo Fuji, et al.. (2021). Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. Bone Marrow Transplantation. 56(9). 2125–2136. 5 indexed citations
12.
Fuji, Shigeo, Hitoshi Yoshida, Eri Watanabe, et al.. (2020). Successful treatment strategy in corporating mogamulizumab and cord blood transplantation in aggressive adult T-cell leukemia-lymphoma: a case report. PubMed. 3(1). 6–10. 1 indexed citations
13.
Yoshida, Hitoshi, et al.. (2020). Different Immune Reconstitution between Cord Blood and unrelated Bone Marrow Transplantation with Relation to Chronic Graft-versus-Host Disease. International Journal of Hematology-Oncology and Stem Cell Research. 14(1). 1–10. 2 indexed citations
14.
Fuji, Shigeo, Yoshihiro Inamoto, Saiko Kurosawa, et al.. (2019). Kinetics of neutrophil engraftment in allogeneic stem cell transplantation. PubMed. 2(2). 22–30.
15.
Kato, Motohiro, Hideki Nakasone, Nobuaki Nakano, et al.. (2019). Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(6). 1023–1028. 2 indexed citations
16.
Ito, Reiko, Yoshihiro Inamoto, Yoshitaka Inoue, et al.. (2018). Characterization of Late Acute and Chronic Graft-Versus-Host Disease according to the 2014 National Institutes of Health Consensus Criteria in Japanese Patients. Biology of Blood and Marrow Transplantation. 25(2). 293–300. 4 indexed citations
17.
Fujiwara, Hiroshi, Shigeo Fuji, Atsushi Wake, et al.. (2017). Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study. Bone Marrow Transplantation. 52(3). 484–488. 15 indexed citations
18.
Kanda, Junya, Kazuhiro Ikegame, Shigeo Fuji, et al.. (2016). Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. Biology of Blood and Marrow Transplantation. 22(11). 2031–2037. 6 indexed citations
19.
Hashimoto, Hisayoshi, Shigehisa Kitano, Ayumu Ito, et al.. (2015). Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 102(1). 101–110. 8 indexed citations
20.
Kanda, Yoshinobu, Junya Kanda, Yoshiko Atsuta, et al.. (2014). Changes in the Clinical Impact of High-Risk Human Leukocyte Antigen Allele Mismatch Combinations on the Outcome of Unrelated Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation. 20(4). 526–535. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saiko Kurosawa Breakdown of academic impact, for papers by Shigesaburo Miyakoshi Breakdown of academic impact, for papers by José Orlando Bordin Breakdown of academic impact, for papers by Susan Light Breakdown of academic impact, for papers by Kavita Raj Breakdown of academic impact, for papers by Marie Garvey Breakdown of academic impact, for papers by Sergio Giralt Breakdown of academic impact, for papers by Flore Sicre de Fontbrune Breakdown of academic impact, for papers by T. K. Chan Breakdown of academic impact, for papers by Hélène Schoemans
Rankless by CCL
2026